Immune Design (IMDZ) Misses Q2 EPS by 7c
Tweet
Share
E-mailGet Alerts IMDZ Hot Sheet
Join SI Premium – FREE
Immune Design (NASDAQ: IMDZ) reported Q2 EPS of ($0.54), $0.07 worse than the analyst estimate of ($0.47).
For earnings history and earnings-related data on Immune Design (IMDZ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Six Flags names Mark Pauls as chief operating officer
- General Mills (GIS) PT Lowered to $42 at Freedom Broker
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
